ACC/AHA Prevention Guideline
... reviewing the highest-quality evidence and partner with other organizations to develop recommendations.2,3 Accordingly, in June 2013 the NHLBI initiated collaboration with the ACC and AHA to work with other organizations to complete and publish the 4 guidelines noted above and make them available to ...
... reviewing the highest-quality evidence and partner with other organizations to develop recommendations.2,3 Accordingly, in June 2013 the NHLBI initiated collaboration with the ACC and AHA to work with other organizations to complete and publish the 4 guidelines noted above and make them available to ...
Ischemic Heart Disease - students 2012 [Read
... • may appear unexpectedly, at rest • often not associated with physical activity • usually a consequence of severe coronary atherosclerosis possibly complicated by a rupture and thrombus formation • management similar to that of MI ...
... • may appear unexpectedly, at rest • often not associated with physical activity • usually a consequence of severe coronary atherosclerosis possibly complicated by a rupture and thrombus formation • management similar to that of MI ...
CHAPTER 2 REVIEW OF LITERATURE SECTION I: COCAINE
... percent of a 96 mg dose. Cocaine snorted through the nasal passages appears in the blood three to five minutes after administration, significantly faster than the 30 minutes required for it to reach the bloodstream through ingestion. However, both ingestion and insufflations result in approximately ...
... percent of a 96 mg dose. Cocaine snorted through the nasal passages appears in the blood three to five minutes after administration, significantly faster than the 30 minutes required for it to reach the bloodstream through ingestion. However, both ingestion and insufflations result in approximately ...
GHB, GBL and 1,4-BD Addiction - Trimbos
... could explain the sudden awakening after several hours of GHBinduced deep sleep, because over time the concentration of GHB in brain decreases to a level at which predominantly GHB receptors are activated and excitation remains [52]. Also, in animal drug discrimination studies, mainly GABAB agonists ...
... could explain the sudden awakening after several hours of GHBinduced deep sleep, because over time the concentration of GHB in brain decreases to a level at which predominantly GHB receptors are activated and excitation remains [52]. Also, in animal drug discrimination studies, mainly GABAB agonists ...
Final Amended Safety Assessment of Sodium Sulfate as Used in
... Sulfate on days 8 through 12 of gestation showed no maternal toxicity.1 No resorptions were observed in treated or control groups; all neonates in the treated group survived from days 1-3. Average birthweight of treated neonates was statistically significantly greater than controls. The researchers ...
... Sulfate on days 8 through 12 of gestation showed no maternal toxicity.1 No resorptions were observed in treated or control groups; all neonates in the treated group survived from days 1-3. Average birthweight of treated neonates was statistically significantly greater than controls. The researchers ...
Study of the interaction between 3,4- methylenedioximethamphetamine and the endocannabinoid system
... addictive drugs are believed to be related to actions on brain reward circuitry, emotional and motivational aspects of dependence may be related to drug-induced adaptations in the same circuitry. These adaptations within reward pathway may be potential mediators of drug withdrawal dysphoric states. ...
... addictive drugs are believed to be related to actions on brain reward circuitry, emotional and motivational aspects of dependence may be related to drug-induced adaptations in the same circuitry. These adaptations within reward pathway may be potential mediators of drug withdrawal dysphoric states. ...
Not for Reprint - Epilepsy Foundation
... Object. The authors evaluated the extent to which the Subdural Pharmacotherapy Device (SPD), chronically implanted over the frontal cortex to perform periodic, localized muscimol-delivery/CSF removal cycles, affects overall behavior, motor performance, electroencephalography (EEG) activity, and bloo ...
... Object. The authors evaluated the extent to which the Subdural Pharmacotherapy Device (SPD), chronically implanted over the frontal cortex to perform periodic, localized muscimol-delivery/CSF removal cycles, affects overall behavior, motor performance, electroencephalography (EEG) activity, and bloo ...
product monograph
... The dosage of ANTITHROMBIN III IMMUNO depends on the cause and severity of AT III deficiency. Antithrombin III activity must be determined for accurate dosage calculation. The normal range of antithrombin III activity in human plasma is between 80% and 120%. A decrease in activity to below 70% of no ...
... The dosage of ANTITHROMBIN III IMMUNO depends on the cause and severity of AT III deficiency. Antithrombin III activity must be determined for accurate dosage calculation. The normal range of antithrombin III activity in human plasma is between 80% and 120%. A decrease in activity to below 70% of no ...
aspartate Antagonists on a Multiple Schedule of Ethanol and
... and they used similar experimental designs. These preliminary results indicate that injections of the competitive NMDA antagonists 2-amino-5-phosphonopentanoic acid (AP-5) and 2-amino-7-phosphonoheptanoic acid (AP-7) directly into the nucleus accumbens attenuate operant responding for 10% ethanol wi ...
... and they used similar experimental designs. These preliminary results indicate that injections of the competitive NMDA antagonists 2-amino-5-phosphonopentanoic acid (AP-5) and 2-amino-7-phosphonoheptanoic acid (AP-7) directly into the nucleus accumbens attenuate operant responding for 10% ethanol wi ...
hydrocodone bitartrate and acetaminophen tablets, usp
... Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Geriatric Use: Clinical studies of hydrocodone bitartrate and acetaminophen tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subj ...
... Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Geriatric Use: Clinical studies of hydrocodone bitartrate and acetaminophen tablets did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subj ...
Administrative Claims Analysis of the Relationship Between
... METHODS: A cohort study sample was drawn from an administrative database comprising medical and pharmacy claims for 1.7 million health plan members. A health plan member was defined as anyone who was eligible for pharmacy and medical benefits at any time from October 1, 2003, to September 30, 2004. ...
... METHODS: A cohort study sample was drawn from an administrative database comprising medical and pharmacy claims for 1.7 million health plan members. A health plan member was defined as anyone who was eligible for pharmacy and medical benefits at any time from October 1, 2003, to September 30, 2004. ...
Frequency, Type and Causes of Medication Errors in Pediatric
... and health care providers(1) and in this regard medication errors are used as the index to assess patient safety in hospitals. Medication errors are one of the most common medical errors(2) and its incidence rate have been reported 5.6 cases per 1000 patient in adults and 14.8 cases per 1000 patient ...
... and health care providers(1) and in this regard medication errors are used as the index to assess patient safety in hospitals. Medication errors are one of the most common medical errors(2) and its incidence rate have been reported 5.6 cases per 1000 patient in adults and 14.8 cases per 1000 patient ...
acetaminophen and codeine phosphate tablets
... Concentration-Efficacy Relationships – The minimum effective analgesic concentration will vary widely among patients, especially among patients who have been previously treated with potent agonist opioids. The minimum effective analgesic concentration of codeine for any individual patient may increa ...
... Concentration-Efficacy Relationships – The minimum effective analgesic concentration will vary widely among patients, especially among patients who have been previously treated with potent agonist opioids. The minimum effective analgesic concentration of codeine for any individual patient may increa ...
2012 Fluoride Therapy Guide
... occurring or added to drinking water, and risk of human cancer. and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Fluoride ion is not mutagenic in standard bacterial systems. It has been s ...
... occurring or added to drinking water, and risk of human cancer. and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Fluoride ion is not mutagenic in standard bacterial systems. It has been s ...
olanzapine - PsychSearch
... milligrams (mg). A lower dose of 5 mg or 7.5 mg may be used when clinically indicated. Efficacy of intramuscular olanzapine has been demonstrated in a dosage range of 2.5 mg to 10 mg (Prod Info ZYPREXA(R) oral tablets, IM injection, ZYPREXA(R) ZYDIS(R) orally disintergating tablets, 2006). b) The ef ...
... milligrams (mg). A lower dose of 5 mg or 7.5 mg may be used when clinically indicated. Efficacy of intramuscular olanzapine has been demonstrated in a dosage range of 2.5 mg to 10 mg (Prod Info ZYPREXA(R) oral tablets, IM injection, ZYPREXA(R) ZYDIS(R) orally disintergating tablets, 2006). b) The ef ...
Digoxin Injection, CSD
... The tolerance of newborn infants to digitalis glycosides is variable, since their renal clearance of the medication is reduced. Premature and immature infants are especially sensitive. Dosage of digoxin should be reduced and individualized according to the infant’s degree of maturity, since renal cl ...
... The tolerance of newborn infants to digitalis glycosides is variable, since their renal clearance of the medication is reduced. Premature and immature infants are especially sensitive. Dosage of digoxin should be reduced and individualized according to the infant’s degree of maturity, since renal cl ...
Botulinum Toxin Injection for Facial Wrinkles
... Botulinum toxin injection for treatment of facial wrinkles is the most frequently performed cosmetic procedure in the United States, and it is one of the most common entry procedures for clinicians seeking to incorporate aesthetic treatments into their practice. Treatment of frown lines and crow’s f ...
... Botulinum toxin injection for treatment of facial wrinkles is the most frequently performed cosmetic procedure in the United States, and it is one of the most common entry procedures for clinicians seeking to incorporate aesthetic treatments into their practice. Treatment of frown lines and crow’s f ...
Dexmedetomidine Use in General Anaesthesia
... stimulation. Different from most of clinically used anesthetics, dexmedetomidine brings about not only a sedativehypnotic effect via an action on a single type of receptors, but also an analgesic effect and an autonomic blockade that is beneficial in cardiac risk situations. Several studies have dem ...
... stimulation. Different from most of clinically used anesthetics, dexmedetomidine brings about not only a sedativehypnotic effect via an action on a single type of receptors, but also an analgesic effect and an autonomic blockade that is beneficial in cardiac risk situations. Several studies have dem ...
ZIDOVUDINE (AZT) - IARC Monographs
... plasma to treatment with either zidovudine at 600 mg per day (n = 1055), zidovudine (same dose) plus didanosine at 400 mg per day (n = 1080) or zidovudine (same dose) plus zalcitabine at 2.25 mg per day (n = 1072). The patients were followed up to September 1995 for a median of 2.5 years (range, 1.8 ...
... plasma to treatment with either zidovudine at 600 mg per day (n = 1055), zidovudine (same dose) plus didanosine at 400 mg per day (n = 1080) or zidovudine (same dose) plus zalcitabine at 2.25 mg per day (n = 1072). The patients were followed up to September 1995 for a median of 2.5 years (range, 1.8 ...
Bilberry - Longwood Herbal Task Force
... Bilberry’s bioflavonoids are potent antioxidants, scavenging free radicals and reducing inflammation10-12. Bilberry is similar in its antioxidant effects to green tea, grape seed extract, pine bark extract and ginkgo13. Bilberry’s flavonoids appear to reduce capillary permeability and fragility, pos ...
... Bilberry’s bioflavonoids are potent antioxidants, scavenging free radicals and reducing inflammation10-12. Bilberry is similar in its antioxidant effects to green tea, grape seed extract, pine bark extract and ginkgo13. Bilberry’s flavonoids appear to reduce capillary permeability and fragility, pos ...
What are the perioperative risk benefits of garlic supplementation
... popular botanicals used today has been well-known in almost every known ancient civilization as a part of the therapeutic regimen for treatment for a variety of ailments. Many patients use garlic in conjunction with prescription medicines to treat hypertension, hyperlipidemia, and cancer. In recent ...
... popular botanicals used today has been well-known in almost every known ancient civilization as a part of the therapeutic regimen for treatment for a variety of ailments. Many patients use garlic in conjunction with prescription medicines to treat hypertension, hyperlipidemia, and cancer. In recent ...
Makena - HCP Home Makena® (hydroxyprogesterone caproate
... – Have conditions that may be affected by fluid retention, such as preeclampsia, epilepsy, cardiac or renal dysfunction – Have a history of clinical depression; Makena should be discontinued if depression recurs – Develop jaundice; consider whether benefit of use warrants continuation – Dev ...
... – Have conditions that may be affected by fluid retention, such as preeclampsia, epilepsy, cardiac or renal dysfunction – Have a history of clinical depression; Makena should be discontinued if depression recurs – Develop jaundice; consider whether benefit of use warrants continuation – Dev ...
Greater Sensitivity to Subjective Effects of Nicotine in Nonsmokers
... procedure (e.g., responding to the sensory effects of the placebo nasal spray procedure). Correlations were done separately for responses to 10 (J-gfltg and to 20 (ig/kg doses because of the possibility of nonlinear dose-response effects of nicotine on subjective responses in nonsmokers (Perkins et ...
... procedure (e.g., responding to the sensory effects of the placebo nasal spray procedure). Correlations were done separately for responses to 10 (J-gfltg and to 20 (ig/kg doses because of the possibility of nonlinear dose-response effects of nicotine on subjective responses in nonsmokers (Perkins et ...
Methadone-Associated Mortality
... Through many years of clinical trials and experience, methadone has been shown to have a favorable safety profile when used as indicated (Stine, et al., 1998; Payte and Zweben, 1988; Zweben and Payte, 1990). Few serious adverse reactions and no cumulative organ damage have been associated with daily ...
... Through many years of clinical trials and experience, methadone has been shown to have a favorable safety profile when used as indicated (Stine, et al., 1998; Payte and Zweben, 1988; Zweben and Payte, 1990). Few serious adverse reactions and no cumulative organ damage have been associated with daily ...
PDF - Cosmetic Ingredient Review
... in one study (Table 5).3,18,23-27 Reported oral LD50 values of glycerin were 4090 - >38 000 mg/kg in mice, 27 000 mg/kg in rabbits, and 77 500 mg/kg in guinea pigs.3,18,23,24,26-29 The dermal LD50 value of glycerin in rats was reported to be >21 900 mg/kg and in rabbits, >18 700 mg/kg.3,26 The appro ...
... in one study (Table 5).3,18,23-27 Reported oral LD50 values of glycerin were 4090 - >38 000 mg/kg in mice, 27 000 mg/kg in rabbits, and 77 500 mg/kg in guinea pigs.3,18,23,24,26-29 The dermal LD50 value of glycerin in rats was reported to be >21 900 mg/kg and in rabbits, >18 700 mg/kg.3,26 The appro ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.